Physician
Norma a Iglesias, MD PA and Associates
Norma a Iglesias, MD PA and Associates was paid $3.19M by Medicaid between Jan 2018 and Dec 2024, across 74 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.
33Billing provider infoNORMA A IGLESIAS, MD PA AND ASSOCIATES
PHARR, TX 78577
PHARR, TX 78577
33aNPI1932205838assigned 09/16/2006
33bProvider typeFamily Medicine Physician
28Total paid$3.19M
24GClaims164,878
24DCodes billed74
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#33 of 1,204
Median peer was paid$31K
This provider vs. median104×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,803 | $16K | |
| 2019 | 2,016 | $20K | |
| 2020 | 11,813 | $266K | |
| 2021 | 37,760 | $806K | |
| 2022 | 45,621 | $1.01M | |
| 2023 | 34,115 | $681K | |
| 2024incomplete | 31,750 | $392K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 23,204 | 18,593 | $738K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 17% | 13,114 | 11,334 | $548K |
| S8301 | Infection control supplies, not otherwise specified | 11% | 13,302 | 11,314 | $343K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9.4% | 4,094 | 3,784 | $301K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.8% | 5,061 | 4,455 | $217K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.4% | 10,938 | 9,748 | $140K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.9% | 10,024 | 4,535 | $126K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.8% | 8,585 | 7,418 | $122K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 15,175 | 13,247 | $89K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.5% | 1,051 | 963 | $80K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 2,781 | 2,448 | $62K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 681 | 644 | $51K |
62 more codes
| 99000 | 1.5% | 5,351 | $48K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 2,903 | $37K |
| 99203 | Doctor's office visit, new patient (routine) | 1.1% | 677 | $36K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 436 | $27K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,634 | $25K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,805 | $19K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 503 | $19K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,113 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 339 | $17K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 195 | $14K |
| 84480 | <1% | 1,321 | $12K | |
| 80061 | Lipid panel | <1% | 2,053 | $11K |
| 84439 | <1% | 1,706 | $10K | |
| 99050 | <1% | 734 | $9K | |
| 92588 | <1% | 579 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,634 | $7K |
| 78268 | <1% | 89 | $6K | |
| 99091 | <1% | 130 | $6K | |
| 81003 | <1% | 3,439 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 500 | $5K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 123 | $5K |
| 90756 | <1% | 294 | $4K | |
| 82947 | <1% | 1,294 | $3K | |
| 82044 | <1% | 1,619 | $3K | |
| 82570 | <1% | 1,617 | $3K | |
| 81025 | <1% | 298 | $2K | |
| 96160 | <1% | 974 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,856 | $2K |
| 96156 | <1% | 60 | $1K | |
| 99490 | Ccm add 20min | <1% | 2,044 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 141 | $1K |
| G0315 | Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt) | <1% | 52 | $1K |
| 0071A | <1% | 27 | $1K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 13 | $981.21 |
| 90620 | <1% | 245 | $962.00 | |
| 78267 | <1% | 88 | $740.06 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 866 | $617.80 |
| 97169 | <1% | 48 | $564.00 | |
| 0012A | <1% | 52 | $454.24 | |
| A4245 | Alcohol wipes, per box | <1% | 1,453 | $432.23 |
| 93000 | <1% | 42 | $422.72 | |
| 0011A | <1% | 51 | $287.98 | |
| 90674 | <1% | 53 | $236.82 | |
| 0013A | <1% | 13 | $200.00 | |
| 90734 | <1% | 186 | $150.23 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 12 | $86.58 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 76 | $59.21 |
| 96161 | <1% | 74 | $44.64 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,291 | $11.70 |
| 90686 | <1% | 642 | $0.64 | |
| 90651 | <1% | 354 | $0.07 | |
| 99401 | 0% | 3,801 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 2,697 | $0.00 |
| 99051 | 0% | 1,846 | $0.00 | |
| 90715 | 0% | 33 | $0.00 | |
| 90670 | 0% | 44 | $0.00 | |
| 36416 | 0% | 2,052 | $0.00 | |
| 96127 | 0% | 87 | $0.00 | |
| 91307 | 0% | 47 | $0.00 | |
| 91301 | 0% | 39 | $0.00 | |
| 99496 | 0% | 13 | $0.00 | |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | 0% | 110 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialIGLESIAS, NORMA (OWNER)